ArticleAnnals of translational medicine2020

Resveratrol activates DNA damage response through inhibition of polo-like kinase 1 (PLK1) in natural killer/T cell lymphoma.

Xianxian Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.